• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】48447

【品名】Di-tert-butyl iminodicarboxylate; Iminodicarboxylic acid di-tert-butyl ester

【CA登记号】51779-32-9

【 分 子 式 】C10H19NO4

【 分 子 量 】217.2652

【元素组成】C 55.28% H 8.81% N 6.45% O 29.46%

与该中间体有关的原料药合成路线共 3 条

合成路线1

该中间体在本合成路线中的序号:(II)

The condensation of bromoketone (I) with di-tert-butyl iminodicarboxylate (II) by means of Cs2CO3 in acetonitrile gives the adduct (III), which is monodecarboxylated by reaction with TFA in dichloromethane to yield the carbamate (IV). The asymmetric reduction of the ketonic group of (IV) by means of BH3 and a chiral oxazaborole catalyst affords the (R)-alcohol (V), which is cyclized by means of NaH in DMF to provide the chiral oxazolidinone (VI). The alkylation of (VI) with 6-(4-phenylbutoxy)hexyl bromide (VII) by means of NaH in THF gives the alkylated oxazolidinone (VIII), which is treated with Tms-OK in THF to cleave the oxazolidinone ring, yielding the aminoalcohol (IX). Finally, the acetonide ring of (IX) is cleaved by means of AcOH in methanol to provide salmeterol.

1 Coe, D.M.; Perciaccante, R.; Procopiou, P.A.; Potassium trimethylsilanolate induced cleavage of 1,3-oxazolidin-2 and 5-ones, and application to the synthesis of (R)-salmeterol. Org Biomol Chem 2003, 1, 7, 1106.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 52359 2-bromo-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1-ethanone C12H13BrO3 详情 详情
(II) 48447 Di-tert-butyl iminodicarboxylate; Iminodicarboxylic acid di-tert-butyl ester 51779-32-9 C10H19NO4 详情 详情
(III) 64766 6-{2-[bis(tert-butoxycarbonyl)amino]acetyl}-2,2-dimethyl-4H-1,3-benzodioxine C22H31NO7 详情 详情
(IV) 64767 tert-butyl 2-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxoethylcarbamate C17H23NO5 详情 详情
(V) 64768 tert-butyl (2R)-2-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-hydroxyethylcarbamate C17H25NO5 详情 详情
(VI) 64769 (5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one C13H15NO4 详情 详情
(VII) 31479 1-[4-[(6-bromohexyl)oxy]butyl]benzene; 6-bromohexyl-4-phenylbutyl ether; 6-Bromohexyloxybutylbenzene 94749-73-2 C16H25BrO 详情 详情
(VIII) 64770 (5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-3-[6-(4-phenylbutoxy)hexyl]-1,3-oxazolidin-2-one C29H39NO5 详情 详情
(IX) 52679 (1R)-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-{[6-(4-phenylbutoxy)hexyl]amino}-1-ethanol C28H41NO4 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XVI)

Reaction of 4-cyanobenzyl bromide (I) with bis(tert-butoxycarbonyl)imine (XVI) by means of NaH in THF gives the protected benzylamine (XVII), which is treated with hydroxylamine and Na2CO3 in ethanol/water to yield the N-hydroxybenzamidine (XVIII). Reduction of compound (XVIII) with H2 over Pd/C in HOAc/Ac2O affords the protected benzamidine (XIX), which is treated with benzyl chloroformate and NaOH in THF in order to obtain the fully protected compound (XX). Selective deprotection of (XX) with HCl gives 4-(benzyloxycarbonylamidino)benzylamine (V), which is condensed with the protected azetidine-2-carboxylic acid (XXI) to afford the corresponding amide (XXII). Boc-deprotection of (XXII) provides azetidine (XXIII), which is condensed with N-Boc-(R)-cyclohexylglycine (VII) to give the protected dipeptide (XI). Boc-deprotection of (XI) affords intermediate (XII), which is condensed with benzyl 2-bromoacetate (XIV) to give the melagatran precursor (XV). Finally, this compound is debenzylated by hydrogenation with H2 over Pd/C as before.

2 Hervé, Y.; Fournier, J.; De Nanteuil, G.; Leborgne, F.; Verbeuren, T.J.; Lila, C.; Gloanec, P.; Cadet, L.; Large scale preparation of protected 4-aminomethylbenzamidine. Application to the synthesis of the thrombin inhibitor melagatran. Synth Commun 1998, 28, 23, 4419.
1 Bayes, M.; Silvestre, J.S.; Sorbera, L.A.; Castaner, J.; Melagatran and Ximelagatran. Drugs Fut 2001, 26, 12, 1155.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14200 4-(Bromomethyl)benzonitrile; alpha-Bromo-p-tolunitrile 17201-43-3 C8H6BrN 详情 详情
(V) 50386 benzyl [4-(aminomethyl)phenyl](imino)methylcarbamate C16H17N3O2 详情 详情
(VII) 35619 (2S)-2-[(tert-butoxycarbonyl)amino]-2-cyclohexylethanoic acid C13H23NO4 详情 详情
(XI) 50376 benzyl [4-([[((2S)-1-[(2R)-2-[(tert-butoxycarbonyl)amino]-2-cyclohexylethanoyl]azetidinyl)carbonyl]amino]methyl)phenyl](imino)methylcarbamate C33H43N5O6 详情 详情
(XII) 50390 benzyl (4-[[([(2S)-1-[(2R)-2-amino-2-cyclohexylethanoyl]azetidinyl]carbonyl)amino]methyl]phenyl)(imino)methylcarbamate C28H35N5O4 详情 详情
(XIV) 12869 benzyl 2-bromoacetate 5437-45-6 C9H9BrO2 详情 详情
(XV) 50392 benzyl 2-[((1R)-2-[(2S)-2-[([4-[[[(benzyloxy)carbonyl]amino](imino)methyl]benzyl]amino)carbonyl]azetidinyl]-1-cyclohexyl-2-oxoethyl)amino]acetate C37H43N5O6 详情 详情
(XVI) 48447 Di-tert-butyl iminodicarboxylate; Iminodicarboxylic acid di-tert-butyl ester 51779-32-9 C10H19NO4 详情 详情
(XVII) 50393 1-[[bis(tert-butoxycarbonyl)amino]methyl]-4-cyanobenzene C18H24N2O4 详情 详情
(XVIII) 50394 1-[amino(hydroxyimino)methyl]-4-[[bis(tert-butoxycarbonyl)amino]methyl]benzene C18H27N3O5 详情 详情
(XIX) 50395 1-[amino(imino)methyl]-4-[[bis(tert-butoxycarbonyl)amino]methyl]benzene C18H27N3O4 详情 详情
(XX) 50396 1-[[[(benzyloxy)carbonyl]amino](imino)methyl]-4-[[bis(tert-butoxycarbonyl)amino]methyl]benzene C26H33N3O6 详情 详情
(XXI) 26205 (2S)-1-(tert-butoxycarbonyl)-2-azetidinecarboxylic acid C9H15NO4 详情 详情
(XXII) 50397 tert-butyl (2S)-2-[([4-[[[(benzyloxy)carbonyl]amino](imino)methyl]benzyl]amino)carbonyl]-1-azetidinecarboxylate C25H30N4O5 详情 详情
(XXIII) 50398 benzyl [4-([[(2S)azetidinylcarbonyl]amino]methyl)phenyl](imino)methylcarbamate C20H22N4O3 详情 详情

合成路线3

该中间体在本合成路线中的序号:(VIII)

Treatment of diamino compound (I) with oxalic acid (II) in refluxing HCl provides tetrahydroquinoxalindione derivative (III), which is then converted into dichloro compound (IV) by reaction with refluxing POCl3. Treatment of (IV) with Na in refluxing MeOH affords dimethoxy quinoxaline (V), which is then brominated by reaction with NBS and AIBN in refluxing CCl4 to give bromomethyl derivative (VI). Nitration of (VI) by reaction with isopropyl nitrate in H2SO4 yields nitro derivative (VII), which is then converted into protected amino methyl derivative (IX) by reaction with di-tert-butyl-iminocarboxylate (VIII) and cesium carbonate in DMF. Removal of the Boc groups of (IX) by means of TFA gives aminomethyl derivative (X), which is then converted into phosphonic dimethyl ester (XII) by first treatment with formaline in EtOH followed by reaction with dimethyl phosphonate (XI), Et3N and trimethylsilyl chloride (TMSCl) in CHCl3. Finally, treatment of (XII) with trimethylsilyl bromide (TMSBr) in CH2Cl2 obtains the desired product.

1 Acklin, P.; Allgeier, H.; Auberson, Y.; Ofner, S.; Veenstra, S.J. (Novartis AG); Substd. aminoalkane phosphonic acids. EP 0934326; US 6117873; WO 9817672 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 48441 2,3-Diaminotoluene; o-Tolylenediamine 2687-25-4 C7H10N2 详情 详情
(II) 15713 Oxalic acid 144-62-7 C2H2O4 详情 详情
(III) 48442 5-methyl-1,4-dihydro-2,3-quinoxalinedione C9H8N2O2 详情 详情
(IV) 48443 2,3-dichloro-5-methylquinoxaline C9H6Cl2N2 详情 详情
(V) 48444 2,3-dimethoxy-5-methylquinoxaline; 3-methoxy-5-methyl-2-quinoxalinyl methyl ether C11H12N2O2 详情 详情
(VI) 48445 5-(bromomethyl)-3-methoxy-2-quinoxalinyl methyl ether; 5-(bromomethyl)-2,3-dimethoxyquinoxaline C11H11BrN2O2 详情 详情
(VII) 48446 5-(bromomethyl)-3-methoxy-7-nitro-2-quinoxalinyl methyl ether; 5-(bromomethyl)-2,3-dimethoxy-7-nitroquinoxaline C11H10BrN3O4 详情 详情
(VIII) 48447 Di-tert-butyl iminodicarboxylate; Iminodicarboxylic acid di-tert-butyl ester 51779-32-9 C10H19NO4 详情 详情
(IX) 48448 5-[[bis(tert-butoxycarbonyl)amino]methyl]-2,3-dimethoxy-7-nitroquinoxaline C21H28N4O8 详情 详情
(X) 48449 (2,3-dimethoxy-7-nitro-5-quinoxalinyl)methanamine; (2,3-dimethoxy-7-nitro-5-quinoxalinyl)methylamine C11H12N4O4 详情 详情
(XI) 32359 dimethyl phosphonate 868-85-9 C2H7O3P 详情 详情
(XII) 48450 dimethyl [[(2,3-dimethoxy-7-nitro-5-quinoxalinyl)methyl]amino]methylphosphonate C14H19N4O7P 详情 详情
Extended Information